Is glucocorticoid bridging therapy associated with later use of glucocorticoids and biological DMARDs during the disease course of patients with rheumatoid arthritis in daily practice? A real-world data analysis

Author(s):
Ouwerkerk, L. van; Bergstra, S.A.; Maarseveen, T.D.; Huizinga, T.W.J.; Knevel, R.; Allaart, C.F.
Published
2024
Publication type
Article / Letter to editor
GlucocorticoidsRheumatoid arthritisObservational data
Date issued
2024-02-01
Language
English
Is part of
Seminars in Arthritis and Rheumatism
hdl
1887/3720692
doi
10.1016/j.semarthrit.2023.152305